Benazepril Impurity 2 | CAS 105260-10-4 - Request Quote
Benazepril Impurity 2
| SZ CAT No: | SZ-B055013 |
| CAS No | 105260-10-4 |
| Mol.F. | C18H14N2O3 |
| Mol.Wt. | 306.3 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Benazepril Impurity 2 is chemically 2-(2-Oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-yl)isoindoline-1,3-dione. Benazepril Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Benazepril Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Benazepril hydrochloride.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 105260-10-4
Purchase 105260-10-4
Order 105260-10-4
Enquire 105260-10-4
price of 105260-10-4
105260-10-4 Supplier
105260-10-4 Manufacturer
105260-10-4 Exporter
buy high quality Benazepril Impurity 2
Purchase Benazepril Impurity 2
Benazepril Impurity 2 suppliers
Benazepril Impurity 2 manufacturers
Benazepril Impurity 2 price
Order Benazepril Impurity 2
Enquire Benazepril Impurity 2
Benazepril Impurity 2 cost
Benazepril Impurity 2 Supplier
Benazepril Impurity 2 Distributor
Benazepril Impurity 2 for Method Validation
Benazepril hydrochloride Reference Standard
Benazepril Impurity 2 for ANDA Filing
Benazepril Impurity 2 for Forced Degradation Studies
Benazepril Impurity 2 Identification Standards
Benazepril Impurity 2 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.